Abstract
To evaluate what at present is known about the relationship between vascular diseases and the development of chronic polyneuropathy, the literature on ischemia and peripheral nerve damage was reviewed with emphasis on chronic ischemia.
References
1.
Italian General Practitioner Study: Chronic symmetric symptomatic polyneuropathy in the elderly: A field screening investigation in two Italian regions. I. Prevalence and general characteristics of the sample. Neurology 1995;45:1832–1836.
2.
Martyn CN, Hughes RA: Epidemiology of peripheral neuropathy. J Neurol Neurosurg Psychiatry 1997;62:310–318.
3.
McLeod JG, Tuck RR, Pollard JD, Cameron J, Walsh JC: Chronic polyneuropathy of undetermined cause. J Neurol Neurosurg Psychiatry 1984;47:530–535.
4.
Corvisier N, Vallat JM, Hugon J, Lubeau M, Dumas M: Les neuropathies de cause indéterminée, étude de 48 cas. Rev Neurol 1987;143:279–283.
5.
Notermans NC, Wokke JH, Lokhorst HM, Franssen H, van der Graaf Y, Jennekens FG: Polyneuropathy associated with monoclonal gammopathy of undetermined significance. A prospective study of the prognostic value of clinical and laboratory abnormalities. Brain 1994;117:1385–1393.
6.
Notermans NC, Wokke JH, Franssen H, van der Graaf Y, Vermeulen M, Van den Berg LH, Bar PR, Jennekens FG: Chronic idiopathic polyneuropathy presenting in middle or old age: A clinical and electrophysiological study of 75 patients. J Neurol Neurosurg Psychiatry 1993;56:1066–1071.
7.
Notermans NC, Wokke JH, van der Graaf Y, Franssen H, van Dijk GW, Jennekens FG: Chronic idiopathic axonal polyneuropathy: A five-year follow-up. J Neurol Neurosurg Psychiatry 1994;57:1525–1527.
8.
McManis PG, Low PA, Lagerlund TD: Microenvironments of nerve: Blood flow and ischemia; in Dyck PJ, Thomas PK, Griffin JW, Low PA, Poduslo JF (eds): Peripheral Neuropathy. Philadelphia, Saunders, 1993, pp 453–473.
9.
Low PA, Tuck RR: Effects of changes of blood pressure, respiratory acidosis and hypoxia on blood flow in the sciatic nerve of the rat. J Physiol (Lond) 1984;347:513–524.
10.
Beggs J, Johnson PC, Olafsen A, Watkins CJ: Innervation of the vasa nervorum: Changes in human diabetics. J Neuropathol Exp Neurol 1992;51:612–629.
11.
Bell MA, Weddell AG: A morphometric study of intrafascicular vessels of mammalian sciatic nerve. Muscle Nerve 1984;7:524–534.
12.
Bell MA, Weddell AG: A descriptive study of the blood vessels of the sciatic nerve in the rat, man and other mammals. Brain 1984;107:871–898.
13.
Low PA, Ward K, Schmelzer JD, Brimijoin S: Ischemic conduction failure and energy metabolism in experimental diabetic neuropathy. Am J Physiol 1985;248:E457–E462.
14.
McManis PG, Low PA, Yao JK: Relationship between nerve blood flow and intercapillary distance in peripheral nerve edema. Am J Physiol 1986;251:E92–E97.
15.
Lagerlund TD, Low PA: A mathematical simulation of oxygen delivery in rat peripheral nerve. Microvasc Res 1987;34:211–222.
16.
Low PA, Lagerlund TD, McManis PG: Nerve blood flow and oxygen delivery in normal, diabetic, and ischemic neuropathy. Int Rev Neurobiol 1989;31:355–438.
17.
Low PA, Schmelzer JD, Ward KK, Yao JK: Experimental chronic hypoxic neuropathy: Relevance to diabetic neuropathy. Am J Physiol 1986;250:E94–E99.
18.
Low PA, Schmelzer JD, Ward KK: The effect of age on energy metabolism and resistance to ischaemic conduction failure in rat peripheral nerve. J Physiol (Lond) 1986;374:263–271.
19.
Korthals JK, Wisniewski HM: Peripheral nerve ischemia. Part 1. Experimental model. J Neurol Sci 1975;24:65–76.
20.
Nukada H, Dyck PJ: Microsphere embolization of nerve capillaries and fiber degeneration. Am J Pathol 1984;115:275–287.
21.
Kihara M, Zollman PJ, Schmelzer JD, Low PA: The influence of dose of microspheres on nerve blood flow, electrophysiology, and fiber degeneration of rat peripheral nerve. Muscle Nerve 1993;16:1383–1389.
22.
Parry GJ, Brown MJ: Arachidonate-induced experimental nerve infarction. J Neurol Sci 1981;50:123–133.
23.
Korthals JK, Korthals MA, Wisniewski HM: Peripheral nerve ischemia: Part 2. Accumulation of organelles. Ann Neurol 1978;4:487–498.
24.
Hess K, Eames RA, Darveniza P, Gilliatt RW: Acute ischaemic neuropathy in the rabbit. J Neurol Sci 1979;44:19–43.
25.
Sladky JT, Greenberg JH, Brown MJ: Regional perfusion in normal and ischemic rat sciatic nerves. Ann Neurol 1985;17:191–195.
26.
Nukada H, Dyck PJ: Acute ischemia causes axonal stasis, swelling, attenuation, and secondary demyelination. Ann Neurol 1987;22:311–318.
27.
McManis PG, Low PA: Factors affecting the relative viability of centrifascicular and subperineurial axons in acute peripheral nerve ischemia. Exp Neurol 1988;99:84–95.
28.
Fujimura H, Lacroix C, Said G: Vulnerability of nerve fibres to ischaemia. A quantitative light and electron microscope study. Brain 1991;114:1929–1942.
29.
Schneider U, Jund R, Nees S, Grafe P: Differences in sensitivity to hyperglycemic hypoxia of isolated rat sensory and motor nerve fibers. Ann Neurol 1992;31:605–610.
30.
Sladky JT, Tschoepe RL, Greenberg JH, Brown MJ: Peripheral neuropathy after chronic endoneurial ischemia. Ann Neurol 1991;29:272–278.
31.
Sasaki H, Kihara M, Zollman PJ, Nickander KK, Smithson IL, Schmelzer JD, Willner CL, Benarroch EE, Low PA: Chronic constriction model of rat sciatic nerve: Nerve blood flow, morphologic and biochemical alterations. Acta Neuropathol (Berl) 1997;93:62–70.
32.
Nukada H, Dyck PJ, Low PA, Lais AC, Sparks MF: Axonal caliber and neurofilaments are proportionately decreased in galactose neuropathy. J Neuropathol Exp Neurol 1986;45:140–150.
33.
Kupers R, Yu W, Persson JK, Xu XJ, Wiesenfeld Hallin Z: Photochemically-induced ischemia of the rat sciatic nerve produces a dose-dependent and highly reproducible mechanical, heat and cold allodynia, and signs of spontaneous pain. Pain 1998;76:45–59.
34.
Thomas PK, Tomlinson DR: Diabetic and hypoglycemic neuropathy; in Dyck PJ, Thomas PK, Griffin JW, Low PA, Poduslo JF (eds): Peripheral Neuropathy. Philadelphia, Saunders, 1993, pp 1219–1250.
35.
Tesfaye S, Malik R, Ward JD: Vascular factors in diabetic neuropathy. Diabetologia 1994;37:847–854.
36.
Stevens MJ, Feldman EL, Greene DA: The aetiology of diabetic neuropathy: The combined roles of metabolic and vascular defects. Diabet Med 1995;12:566–579.
37.
Dyck PJ, Giannini C: Pathologic alterations in the diabetic neuropathies of humans: A review. J Neuropathol Exp Neurol 1996;55:1181–1193.
38.
Tuck RR, Schmelzer JD, Low PA: Endoneurial blood flow and oxygen tension in the sciatic nerves of rats with experimental diabetic neuropathy. Brain 1984;107:935–950.
39.
Nukada H: Mild ischemia causes severe pathological changes in experimental diabetic nerve. Muscle Nerve 1992;15:1116–1122.
40.
Zochodne DW, Cheng C, Sun H: Diabetes increases sciatic nerve susceptibility to endothelin-induced ischemia. Diabetes 1996;45:627–632.
41.
Said G, Lacroix Ciaudo C, Fujimura H, Blas C, Faux N: The peripheral neuropathy of necrotizing arteritis: A clinicopathological study. Ann Neurol 1988;23:461–465.
42.
Said G: Vasculitic neuropathy. Baillières Clin Neurol 1995;4:489–503.
43.
Dyck PJ, Benstead TJ, Conn DL, Stevens JC, Windebank AJ, Low PA: Nonsystemic vasculitic neuropathy. Brain 1987;110:843–853.
44.
Panegyres PK, Blumbergs PC, Leong AS, Bourne AJ: Vasculitis of peripheral nerve and skeletal muscle: Clinicopathological correlation and immunopathic mechanisms. J Neurol Sci 1990;100:193–202.
45.
Olney RK: Neuropathies in connective tissue disease. Muscle Nerve 1992;15:531–542.
46.
Jennette JC, Falk RH: Small-vessel vasculitis. N Engl J Med 1997;337:1512–1523.
47.
Hawke SH, Davies L, Pamphlett R, Guo YP, Pollard JD, McLeod JG: Vasculitic neuropathy. A clinical and pathological study. Brain 1991;114:2175–2190.
48.
Chalk CH, Dyck PJ, Conn DL: Vasculitic neuropathy; in Dyck PJ, Thomas PK, Griffin JW, Low PA, Poduslo JF (eds): Peripheral Neuropathy. Philadelphia, Saunders, 1993, pp 1424–1436.
49.
Peat DS, Mathieson PW: Cholesterol emboli may mimic systemic vasculitis. BMJ 1996;313:546–547.
50.
Hamuryudan V, Ozdogan H, Yazici H: Other forms of vasculitis and pseudovasculitis. Baillières Clin Rheumatol 1997;11:349–350.
51.
Gemignani F, Pavesi G, Fiocchi A, Manganelli P, Ferraccioli G, Marbini A: Peripheral neuropathy in essential mixed cryoglobulinaemia. J Neurol Neurosurg Psychiatry 1992;55:116–120.
52.
Brouet JC, Clauvel JP, Danon F: Biologic and clinical significance of cryoglobulins. A report of 86 cases. Am J Med 1974;57:775–788.
53.
Cream JJ, Hern JEC, Hughes RAC, Mackenzie ICK: Mixed or immune complex cryoglobulinemia and neuropathy. J Neurol Neurosurg Psychiatry 1974;37:82–87.
54.
Ferri C, La Civita L, Cirafisi C, Siciliano G, Longombardo G, Bombardieri S, Rossi B: Peripheral neuropathy in mixed cryoglobulinemia: Clinical and electrophysiologic investigations. J Rheumatol 1992;19:889–895.
55.
Vallat JM, Desproges Gotteron R, Leboutet MJ, Loubet A, Gualde N, Treves R: Cryoglobulinemic neuropathy: A pathological study. Ann Neurol 1980;8:179–185.
56.
Prior R, Schober R, Scharffetter K, Wechsler W: Occlusive microangiopathy by immunoglobulin (IgM-kappa) precipitation: Pathogenetic relevance in paraneoplastic cryoglobulinemic neuropathy. Acta Neuropathol (Berl) 1992;83:423–426.
57.
Wytrzes L, Markley HG, Fisher M, Alfred HJ: Brachial neuropathy after brachial artery-antecubital vein shunts for chronic hemodialysis. Neurology 1987;37:1398–1400.
58.
Lazarides MK, Staamos DN, Panagopoulos GN, Tzilalis VD, Eleftheriou GJ, Dayantas JN: Indications for surgical treatment of angioaccess-induced arterial ‘steal’. J Am Coll Surg 1998;187:422–426.
59.
Morsy AH, Kulbaski M, Chen C, Isiklar H, Lumsden AB: Incidence and characteristics of patients with hand ischemia after a hemodialysis access procedure. J Surg Res 1998;74:8–10.
60.
Wilbourn AJ, Furlan AJ, Hulley W, Ruschhaupt W: Ischemic monomelic neuropathy. Neurology 1983;33:447–451.
61.
D’Amour ML, Lebrun LH, Rabbat A, Trudel J, Daneault N: Peripheral neurological complications of aortoiliac vascular disease. Can J Neurol Sci 1987;14:127–130.
62.
Nukada H, van Rij AM, Packer SG, McMorran PD: Pathology of acute and chronic ischaemic neuropathy in atherosclerotic peripheral vascular disease. Brain 1996;119:1449–1460.
63.
Lachance DH, Daube JR: Acute peripheral arterial occlusion: Electrophysiologic study of 32 cases. Muscle Nerve 1991;14:633–639.
64.
Larson WL, Wald JJ: Foot drop as a harbinger of aortic occlusion. Muscle Nerve 1995;18:899–903.
65.
Newrick PG, Wilson AJ, Jakubowski J, Boulton AJ, Ward JD: Sural nerve oxygen tension in diabetes. Br Med J (Clin Res Ed) 1986;293:1053–1054.
66.
Tesfaye S, Harris N, Jakubowski JJ, Mody C, Wilson RM, Rennie IG, Ward JD: Impaired blood flow and arterio-venous shunting in human diabetic neuropathy: A novel technique of nerve photography and fluorescein angiography. Diabetologia 1993;36:1266–1274.
67.
Fagerberg SE: Diabetic neuropathy. Acta Med Scand 1959;345:1–97.
68.
Williams E, Timperley WR, Ward JD, Duckworth T: Electron microscopical studies of vessels in diabetic peripheral neuropathy. J Clin Pathol 1980;33:462–470.
69.
Johnson PC, Doll SC, Cromey DW: Pathogenesis of diabetic neuropathy. Ann Neurol 1986;19:450–457.
70.
Dyck PJ, Karnes JL, O’Brien P, Okazaki H, Lais A, Engelstad J: The spatial distribution of fiber loss in diabetic polyneuropathy suggests ischemia. Ann Neurol 1986;19:440–449.
71.
Yasuda H, Dyck PJ: Abnormalities of endoneurial microvessels and sural nerve pathology in diabetic neuropathy. Neurology 1987;37:20–28.
72.
Malik RA, Newrick PG, Sharma AK, Jennings A, Ah See AK, Mayhew TM, Jakubowski J, Boulton AJ, Ward JD: Microangiopathy in human diabetic neuropathy: Relationship between capillary abnormalities and the severity of neuropathy. Diabetologia 1989;32:92–102.
73.
Britland ST, Young RJ, Sharma AK, Clarke BF: Relationship of endoneurial capillary abnormalities to type and severity of diabetic polyneuropathy. Diabetes 1990;39:909–913.
74.
Malik RA, Veves A, Masson EA, Sharma AK, Ah See AK, Schady W, Lye RH, Boulton AJ: Endoneurial capillary abnormalities in mild human diabetic neuropathy. J Neurol Neurosurg Psychiatry 1992;55:557–561.
75.
Malik RA, Tesfaye S, Thompson SD, Veves A, Sharma AK, Boulton AJ, Ward JD: Endoneurial localisation of microvascular damage in human diabetic neuropathy. Diabetologia 1993;36:454–459.
76.
Giannini C, Dyck PJ: Ultrastructural morphometric abnormalities of sural nerve endoneurial microvessels in diabetes mellitus. Ann Neurol 1994;36:408–415.
77.
Giannini C, Dyck PJ: Basement membrane reduplication and pericyte degeneration precede development of diabetic polyneuropathy and are associated with its severity. Ann Neurol 1995;37:498–504.
78.
Ford I, Malik RA, Newrick PG, Preston FE, Ward JD, Greaves M: Relationships between haemostatic factors and capillary morphology in human diabetic neuropathy. Thromb Haemost 1992;68:628–633.
79.
Poduslo JF, Curran GL, Dyck PJ: Increase in albumin, IgG, and IgM blood-nerve barrier indices in human diabetic neuropathy. Proc Natl Acad Sci USA 1988;85:4879–4883.
80.
Valensi P, Behar A, Attalah M, Cohen Boulakia F, Paries J, Attali JR: Increased capillary filtration of albumin in diabetic patients – relation with gender, hypertension, microangiopathy, and neuropathy. Metabolism 1998;47:503–507.
81.
Ram Z, Sadeh M, Walden R, Adar R: Vascular insufficiency quantitatively aggravates diabetic neuropathy. Arch Neurol 1991;48:239–242.
82.
Veves A, Donaghue VM, Sarnow MR, Giurini JM, Campbell DR, LoGerfo FW: The impact of reversal of hypoxia by revascularization on the peripheral nerve function of diabetic patients. Diabetologia 1996;39:44–48.
83.
Harris M, Eastman R, Cowie C: Symptoms of sensory neuropathy in adults with NIDDM in the U.S. population. Diabetes Care 1993;16:1446–1452.
84.
Tesfaye S, Malik R, Harris N, Jakubowski JJ, Mody C, Rennie IG, Ward JD: Arterio-venous shunting and proliferating new vessels in acute painful neuropathy of rapid glycaemic control (insulin neuritis). Diabetologia 1996;39:329–335.
85.
Forrest KY, Maser RE, Pambianco G, Becker DJ, Orchard TJ: Hypertension as a risk factor for diabetic neuropathy: A prospective study. Diabetes 1997;46:665–670.
86.
Nowak D, Bruch M, Arnaud F, Fabel H, Kiessling D, Nolte D, Overlack A, Rolke M, Ulmer WT, Worth H, et al: Peripheral neuropathies in patients with chronic obstructive pulmonary disease: A multicenter prevalence study. Lung 1990;168:43–51.
87.
Bone G, Ladurner G, Rolke M, Nolte D: Peripheral nerve dysfunction in chronic obstructive pulmonary disease; in Asbury AK, Budka H, Sluga E (eds): Sensory Neuropathies. New York, Springer, 1995, pp 143–150.
88.
Malik RA, Masson EA, Sharma AK, Lye RH, Ah See AK, Compton AM, Tomlinson DR, Hanley SP, Boulton AJ: Hypoxic neuropathy: Relevance to human diabetic neuropathy. Diabetologia 1990;33:311–318.
89.
Stoebner P, Mezin P, Vila A, Grosse R, Kopp N, Paramelle B: Microangiopathy of endoneurial vessels in hypoxemic chronic obstructive pulmonary disease (COPD). A quantitative ultrastructural study. Acta Neuropathol (Berl) 1989;78:388–395.
90.
Yiannikas C, McLeod JG, Walsh JC: Peripheral neuropathy associated with polycythemia vera. Neurology 1983;33:139–143.
91.
Poza JJ, Cobo AM, Marti Masso JF: Peripheral neuropathy associated with polycythemia vera. Neurologia 1996;11:276–279.
92.
Criqui MH, Fronek A, Klauber MR, Barrett Connor E, Gabriel S: The sensitivity, specificity, and predictive value of traditional clinical evaluation of peripheral arterial disease: Results from noninvasive testing in a defined population. Circulation 1985;71:516–522.
93.
Ruckley CV: Symptomatic and asymptomatic disease; in Fowkes FGR (ed): Epidemiology of Peripheral Vascular Disease. London, Springer, 1991, pp 97–108.
94.
Meijer WT, Hoes AW, Rutgers D, Bots ML, Hofman A, Grobbee DE: Peripheral arterial disease in the elderly: The Rotterdam Study. Arterioscler Thromb Vasc Biol 1998;18:185–192.
95.
Mufson I: Diagnosis and treatment of neural complications of peripheral arterial obliterative disease. Angiology 1952;3:392–396.
96.
Hutchinson EC, Liversedge LA: Neuropathy in peripheral vascular disease, its bearing on diabetic neuropathy. Q J Med 1956;25:267–274.
97.
Eames RA, Lange LS: Clinical and pathological study of ischaemic neuropathy. J Neurol Neurosurg Psychiatry 1967;30:215–226.
98.
Laghi Pasini F, Pastorelli M, Beermann U, de Candia S, Gallo S, Blardi P, Di Perri T: Peripheral neuropathy associated with ischemic vascular disease of the lower limbs. Angiology 1996;47:569–577.
99.
Miglietta O, Lowenthal M: Nerve conduction velocity and refractory period in peripheral vascular disease. J Appl Physiol 1962;17:837–840.
100.
Miglietta O, Lowenthal M: Nerve motor fiber characteristics in chronic ischemia. Arch Neurol 1966;14:448–453.
101.
Chopra JS, Hurwitz LJ: A comparative study of peripheral nerve conduction in diabetes and non-diabetic chronic occlusive peripheral vascular disease. Brain 1969;92:83–96.
102.
Hunter GC, Song GW, Nayak NN, Zapotowski D, Guernsey JM: Peripheral nerve conduction abnormalities in lower extremity ischemia: The effects of revascularization. J Surg Res 1988;45:96–103.
103.
Garven HSD, Gairns FW, Smith G: The nerve fibre populations of the nerves of the leg in chronic occlusive arterial disease in man. Scot Med J 1962;7:250–265.
104.
Vital C, Le Blanc M, Vallat JM, Cocquet M, Vallat M, Roques JC: Etude ultrastructurale du nerf périphérique chez 16 diabétiques sans neuropathie clinique. Comparaisons avec 16 neuropathies diabétiques et 16 neuropathies nondiabétiques. Acta Neuropathol (Berl) 1974;30:63–72.
105.
Farinon AM, Marbini A, Gemignani F, Govoni E, Bragaglia MM, Sianesi M, Tedeschi F: Skeletal muscle and peripheral nerve changes caused by chronic arterial insufficiency – Significance and clinical correlations – histological, histochemical and ultrastructural study. Clin Neuropathol 1984;3:240–252.
106.
Rodriguez Sanchez C, Medina Sanchez M, Malik RA, Ah See AK, Sharma AK: Morphological abnormalities in the sural nerve from patients with peripheral vascular disease. Histol Histopathol 1991;6:63–71.
107.
England JD, Regensteiner JG, Ringel SP, Carry MR, Hiatt WR: Muscle denervation in peripheral arterial disease. Neurology 1992;42:994–999.
108.
Yao JK, Low PA: Improvement of endoneurial lipid abnormalities in experimental diabetic neuropathy by oxygen modification. Brain Res 1986;362:362–365.
109.
Low PA, Schmelzer JD, Ward KK, Curran GL, Poduslo JF: Effect of hyperbaric oxygenation on normal and chronic streptozotocin diabetic peripheral nerves. Exp Neurol 1988;99:201–212.
110.
Kihara M, McManis PG, Schmelzer JD, Kihara Y, Low PA: Experimental ischemic neuropathy: Salvage with hyperbaric oxygenation. Ann Neurol 1995;37:89–94.
111.
Kappelle AC, Biessels G, Bravenboer B, van Buren T, Traber J, de Wildt DJ, Gispen WH: Beneficial effect of the Ca2+ antagonist, nimodipine, on existing diabetic neuropathy in the BB/W or rat. Br J Pharmacol 1994;111:887–893.
112.
Maxfield EK, Love A, Cotter MA, Cameron NE: Nerve function and regeneration in diabetic rats: Effects of ZD-7155. Am J Physiol 1995;269:E530–E537.
113.
Cotter MA, Love A, Watt MJ, Cameron NE, Dines KC: Effects of natural free radical scavengers on peripheral nerve and neurovascular function in diabetic rats. Diabetologia 1995;38:1285–1294.
114.
Young MJ, Veves A, Smith JV, Walker MG, Boulton AJ: Restoring lower limb blood flow improves conduction velocity in diabetic patients. Diabetologia 1995;38:1051–1054.
115.
Reja A, Tesfaye S, Harris ND, Ward JD: Is ACE inhibition with lisinopril helpful in diabetic neuropathy? Diabet Med 1995;12:307–309.
© 2000 S. Karger AG, Basel
2000
Copyright / Drug Dosage / Disclaimer
Copyright: All rights reserved. No part of this publication may be translated into other languages, reproduced or utilized in any form or by any means, electronic or mechanical, including photocopying, recording, microcopying, or by any information storage and retrieval system, without permission in writing from the publisher.
Drug Dosage: The authors and the publisher have exerted every effort to ensure that drug selection and dosage set forth in this text are in accord with current recommendations and practice at the time of publication. However, in view of ongoing research, changes in government regulations, and the constant flow of information relating to drug therapy and drug reactions, the reader is urged to check the package insert for each drug for any changes in indications and dosage and for added warnings and precautions. This is particularly important when the recommended agent is a new and/or infrequently employed drug.
Disclaimer: The statements, opinions and data contained in this publication are solely those of the individual authors and contributors and not of the publishers and the editor(s). The appearance of advertisements or/and product references in the publication is not a warranty, endorsement, or approval of the products or services advertised or of their effectiveness, quality or safety. The publisher and the editor(s) disclaim responsibility for any injury to persons or property resulting from any ideas, methods, instructions or products referred to in the content or advertisements.
You do not currently have access to this content.
